相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNET
Marc Garcia-Moure et al.
CLINICAL CANCER RESEARCH (2021)
Delta-24 adenoviral therapy for glioblastoma: evolution from the bench to bedside and future considerations
Chibawanye I. Ene et al.
NEUROSURGICAL FOCUS (2021)
Adenovirus Receptor Expression in Cancer and Its Multifaceted Role in Oncolytic Adenovirus Therapy
Lobke C. M. Hensen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Oncolytic viruses: how lytic must they be for therapeutic efficacy?
Maria Eugenia Davola et al.
ONCOIMMUNOLOGY (2019)
The oncolytic virus Delta-24-RGD elicits an antitumor effect in pediatric glioma and DIPG mouse models
Naiara Martinez-Velez et al.
NATURE COMMUNICATIONS (2019)
Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma
Juri Kiyokawa et al.
ONCOLYTIC VIROTHERAPY (2019)
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma
Frederick F. Lang et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Novel Vector Construction Based on Alternative Adenovirus Types via Homologous Recombination
Wenli Zhang et al.
HUMAN GENE THERAPY METHODS (2018)
A compendium of adenovirus genetic modifications for enhanced replication, oncolysis, and tumor immunosurveillance in cancer therapy
Aleksei A. Stepanenko et al.
GENE (2018)
Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX
Aleksei A. Stepanenko et al.
VIRUS RESEARCH (2018)
Combined Genetic and Chemical Capsid Modifications of Adenovirus-Based Gene Transfer Vectors for Shielding and Targeting
Franziska Jonsson et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2018)
Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?
Aleksei A. Stepanenko et al.
CANCERS (2018)
An evaluation of the antioxidant properties of iodinated radiographic contrast media: An in vitro study
Montree Tungjai et al.
TOXICOLOGY REPORTS (2018)
Viral Aggregation: Impact on Virus Behavior in the Environment
Charles P. Gerba et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2017)
Immunohistochemical Characterization and Sensitivity to Human Adenovirus Serotypes 3, 5, and 11p of New Cell Lines Derived from Human Diffuse Grade II to IV Gliomas
Minna Niittykoski et al.
TRANSLATIONAL ONCOLOGY (2017)
A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model
Julius W. Kim et al.
MOLECULAR THERAPY-ONCOLYTICS (2017)
A Comprehensive Evaluation of the Activity and Selectivity Profile of Ligands for RGD-binding Integrins
Tobias G. Kapp et al.
SCIENTIFIC REPORTS (2017)
Intratumoral delivery of inactivated modified vaccinia virus Ankara (iMVA) induces systemic antitumor immunity via STING and Batf3-dependent dendritic cells
Peihong Dai et al.
SCIENCE IMMUNOLOGY (2017)
Aggregation of Adenovirus 2 in Source Water and Impacts on Disinfection by Chlorine
Amy M. Kahler et al.
FOOD AND ENVIRONMENTAL VIROLOGY (2016)
Engineered adenoviruses combine enhanced oncolysis with improved virus production by mesenchymal stromal carrier cells
Katharina Hammer et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
A novel immunocompetent murine model for replicating oncolytic adenoviral therapy
L. Zhang et al.
CANCER GENE THERAPY (2015)
A Multi Targeting Conditionally Replicating Adenovirus Displays Enhanced Oncolysis while Maintaining Expression of Immunotherapeutic Agents
G. Clement Dobbins et al.
PLOS ONE (2015)
The therapeutic efficacy of the oncolytic virus Delta24-RGD in a murine glioma model depends primarily on antitumor immunity
Anne Kleijn et al.
ONCOIMMUNOLOGY (2014)
Influence of Inorganic Ions on Aggregation and Adsorption Behaviors of Human Adenovirus
Kelvin Wong et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2012)
The disulfide bond of an RGD4C motif inserted within the Hi loop of the adenovirus type 5 fiber protein is critical for retargeting to αv-integrins
Dragomira Majhen et al.
JOURNAL OF GENE MEDICINE (2012)
Adaptive Antiviral Immunity Is a Determinant of the Therapeutic Success of Oncolytic Virotherapy
Paul T. Sobol et al.
MOLECULAR THERAPY (2011)
Single-cycle viral gene expression, rather than progressive replication and oncolysis, is required for VSV therapy of B16 melanoma
F. Galivo et al.
GENE THERAPY (2010)
CRAdRGDflt-IL24 virotherapy in combination with chemotherapy of experimental glioma
L. N. Kaliberova et al.
CANCER GENE THERAPY (2009)
Immune-Mediated Antitumor Activity of Reovirus Is Required for Therapy and Is Independent of Direct Viral Oncolysis and Replication
Robin J. Prestwich et al.
CLINICAL CANCER RESEARCH (2009)
Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma
Sophy Zheng et al.
JOURNAL OF GENE MEDICINE (2007)
Enhanced transduction of malignant glioma with a double targeted Ad5/3-RGD fiber-modified adenovirus
Matthew A. Tyler et al.
MOLECULAR CANCER THERAPEUTICS (2006)
A rapid and efficient method for purification of recombinant adenovirus with arginine-glycine-aspartic acid-modified fibers
Henry H. Peng et al.
ANALYTICAL BIOCHEMISTRY (2006)
Development of a purification process for adenovirus: Controlling virus aggregation to improve the clearance of host cell DNA
JO Konz et al.
BIOTECHNOLOGY PROGRESS (2005)
Iodinated radiographic contrast media possess antioxidant properties in vitro
K Berg et al.
ACTA RADIOLOGICA (2005)
Combined genetic and chemical capsid modifications enable flexible and efficient de- and retargeting of adenovirus vectors
F Kreppel et al.
MOLECULAR THERAPY (2005)
Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors
AV Borovjagin et al.
CANCER GENE THERAPY (2005)
Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells
P Hölig et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2004)
Development of stable liquid formulations for adenovirus- based vaccines
RK Evans et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Efficient internalization into low-passage glioma cell lines using adenoviruses other than type 5: an approach for improvement of gene delivery to brain tumours
J Skog et al.
JOURNAL OF GENERAL VIROLOGY (2004)
Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway
J Fueyo et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Expression of the coxsackie and adenovirus receptor in human astrocytic tumors and xenografts
J Fuxe et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Developing novel oncolytic adenoviruses through bioselection
W Yan et al.
JOURNAL OF VIROLOGY (2003)
An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy
C Heise et al.
NATURE MEDICINE (2000)
The coxsackievirus-adenovirus receptor protein as a cell adhesion molecule in the developing mouse brain
T Honda et al.
MOLECULAR BRAIN RESEARCH (2000)
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
J Fueyo et al.
ONCOGENE (2000)
分享论文
